Redpoint Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Redpoint Investment Management's LLY Position: Q3 2022 in Review
Redpoint Investment Management reduced its Eli Lilly (LLY) stake by 14% in Q3 2022, selling an estimated $867K and leaving 17,414 shares worth $5.63M. The position accounts for 0.82% of the portfolio, ranked #17.
Redpoint Investment Management first reported a position in LLY in Q4 2017 and has held it in 20 quarters since. The position peaked at $8.83M in Q1 2020. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Redpoint Investment Management held 17,414 shares of Eli Lilly worth $5.63M as of Q3 2022.
- Redpoint Investment Management sold 2,738 Eli Lilly shares in Q3 2022, an estimated $867K.
- Eli Lilly made up 0.82% of Redpoint Investment Management's portfolio in Q3 2022, its #17 holding.
- Redpoint Investment Management first reported a position in Eli Lilly in Q4 2017 and has held it in 20 quarters since.
- Redpoint Investment Management's Eli Lilly position peaked at $8.83M in Q1 2020.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.